Fischer B R, Speckmann E J, Greiner C, Gorji A, Wölfer J, Wassmann H
Department of Neurosurgery, University Hospital of Münster (UKM), Albert-Schweitzer-Strasse 33, 48129, Münster, Germany.
Acta Neurochir (Wien). 2009 Apr;151(4):415-8. doi: 10.1007/s00701-009-0228-2. Epub 2009 Mar 11.
The therapeutic use of pure oxygen, even under hyperbaric conditions, has been well established for about 50 years, whereas the discovery of oxygen occurred 250 years earlier. Many neurosurgical patients suffer from brain tissue damage, due to reduced blood flow, obstructive vessel disease, or as a result of traumatic brain injury.
The application of pure oxygen in these patients is the only method of increasing the O(2) concentration in tissue with impaired blood supply and can minimize secondary impairment of brain tissue.
In this brief historical overview we focus on the development and evidence of hyperbaric oxygenation in this specific field of insufficient oxygen supply to the central neural tissue.
With the use of modern biological methods and new study designs, HBO has a place in evidence-based treatment of patients with neural tissue damage.
纯氧的治疗用途,即使是在高压条件下,已经有大约50年的充分实践,而氧气的发现则早了250年。许多神经外科患者因血流减少、血管阻塞性疾病或创伤性脑损伤而遭受脑组织损伤。
在这些患者中应用纯氧是增加血液供应受损组织中氧浓度的唯一方法,并且可以将脑组织的继发性损伤降至最低。
在这个简短的历史概述中,我们关注在中枢神经组织氧气供应不足这一特定领域高压氧疗的发展和证据。
随着现代生物学方法和新研究设计的应用,高压氧疗在神经组织损伤患者的循证治疗中占有一席之地。